Company Analysis Betta Pharmaceuticals Co., Ltd.
1. Summary
Advantages
- The stock's return over the last year (-16.81%) is higher than the sector average (-36.11%).
- Current debt level 0% is below 100% and has decreased over 5 years from 22.46%.
Disadvantages
- Price (37.36 Β₯) is higher than fair price (2.85 Β₯)
- Dividends (0.15%) are below the sector average (1.83%).
- The company's current efficiency (ROE=1.91%) is lower than the sector average (ROE=11.95%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Betta Pharmaceuticals Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1.2% | -4.6% | 0.5% |
| 90 days | -0.5% | -16% | 15% |
| 1 year | -16.8% | -36.1% | 22% |
300558 vs Sector: Betta Pharmaceuticals Co., Ltd. has outperformed the "Healthcare" sector by 19.3% over the past year.
300558 vs Market: Betta Pharmaceuticals Co., Ltd. has significantly underperformed the market by -38.78% over the past year.
Stable price: 300558 is not significantly more volatile than the rest of the market on "Shenzhen Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 300558 with weekly volatility of -0.3233% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (37.36 Β₯) is higher than the fair price (2.85 Β₯).
Price is higher than fair: The current price (37.36 Β₯) is 92.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (177.04) is higher than that of the sector as a whole (69.4).
P/E vs Market: The company's P/E (177.04) is higher than that of the market as a whole (63.57).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.08) is higher than that of the sector as a whole (3.96).
P/BV vs Market: The company's P/BV (4.08) is higher than that of the market as a whole (3.79).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (8.6) is higher than that of the sector as a whole (6.51).
P/S vs Market: The company's P/S indicator (8.6) is higher than that of the market as a whole (5.87).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (89.7) is higher than that of the sector as a whole (11.85).
EV/Ebitda vs Market: The company's EV/Ebitda (89.7) is higher than that of the market as a whole (25.54).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -10.2% over the last 5 years.
Earnings Slowdown: The last year's return (-67.5%) is below the 5-year average return (-10.2%).
Profitability vs Sector: The return for the last year (-67.5%) is lower than the return for the sector (13.28%).
5.4. ROE
ROE vs Sector: The company's ROE (1.91%) is lower than that of the sector as a whole (11.95%).
ROE vs Market: The company's ROE (1.91%) is lower than that of the market as a whole (9.38%).
5.5. ROA
ROA vs Sector: The company's ROA (0.6%) is lower than that of the sector as a whole (5.4%).
ROA vs Market: The company's ROA (0.6%) is lower than that of the market as a whole (3.95%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.15% is below the average for the sector '1.83%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.15% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 0.15% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (92.59%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
